Spots Global Cancer Trial Database for small cell lung cancer
Every month we try and update this database with for small cell lung cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Study of Gimatecan (ST1481) in Small Cell Lung Cancer | NCT04501029 | Small Cell Lung... | Gimatecan | 18 Years - 75 Years | Lee's Pharmaceutical Limited | |
| Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Cancer | NCT01642251 | Extensive Stage... Large Cell Lung... Neuroendocrine ... Small Cell Carc... Stage IV Non-Sm... | Cisplatin Etoposide Veliparib Placebo | 18 Years - | National Cancer Institute (NCI) | |
| A Prospective Longitudinal Collection of Subjects Diagnosed With Small Cell Lung Cancer | NCT01591512 | Small Cell Lung... | 18 Years - | Fujirebio Diagnostics, Inc. | ||
| Irinotecan/Cisplatin Plus Simvastatin in Extensive Disease-Small Cell Lung Cancer (ED-SCLC) | NCT00452634 | Small Cell Lung... | Irinotecan Cisplatin Simvastatin | 18 Years - | National Cancer Center, Korea | |
| Panomic Approach to Immune-Connected Assays in Small Cell Lung Cancer | NCT05797493 | Small Cell Lung... | Atezolizumab | 18 Years - | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | |
| Motivational Counseling in Preventing Smoking Relapse After Pregnancy in Pregnant Women Who Quit Smoking During Pregnancy | NCT00310115 | Bladder Cancer Cervical Cancer Esophageal Canc... Gastric Cancer Head and Neck C... Kidney Cancer Leukemia Liver Cancer Lung Cancer Pancreatic Canc... Tobacco Use Dis... | Smoking Prevent... Counseling Inte... Counseling Inte... | 18 Years - | M.D. Anderson Cancer Center | |
| AZD 2811 Monotherapy in Relapsed Small Cell Lung Cancer Patients [SUKSES-N3] | NCT03366675 | Small Cell Lung... | AZD2811 | 20 Years - | Samsung Medical Center | |
| Green Tea Extract in Preventing Cancer in Former and Current Heavy Smokers With Abnormal Sputum | NCT00573885 | Lung Cancer Tobacco Use Dis... | defined green t... placebo | 45 Years - 74 Years | British Columbia Cancer Agency | |
| Study of Durvalumab + Tremelimumab, Durvalumab, and Placebo in Limited Stage Small-Cell Lung Cancer in Patients Who Have Not Progressed Following Concurrent Chemoradiation Therapy | NCT03703297 | Small Cell Lung... | Durvalumab Tremelimumab Placebo | 18 Years - 130 Years | AstraZeneca | |
| Neoadjuvant Therapy With Toripalimab and JS004 Combined With Etoposide and Platinum Chemotherapy for Limited-stage Small Cell Lung Cancer : A Phase 2 Trial | NCT06256237 | Limited Stage S... | JS004 Toripalimab surgery Etoposide Platinum | 18 Years - | Shanghai Pulmonary Hospital, Shanghai, China | |
| Picoplatin as Second-Line Therapy for Patients With Small Cell Lung Cancer | NCT00116610 | Small Cell Lung... | picoplatin | 18 Years - | Poniard Pharmaceuticals | |
| Development and Validation of Nomogram Predicting Survival in Chinese SCLC Patients | NCT05673798 | Small Cell Lung... | initial chemoth... | - | The Second Hospital of Shandong University | |
| A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer | NCT06095505 | Small Cell Lung... | Alisertib | 18 Years - | Puma Biotechnology, Inc. | |
| Lisinopril in Reducing Shortness of Breath Caused by Radiation Therapy in Patients With Lung Cancer | NCT01880528 | Dyspnea Non-small Cell ... Small Cell Lung... | lisinopril placebo | 18 Years - | Mayo Clinic | |
| A Phase 1/2 Study of BA3071 as Monotherapy and in Combination With a PD-1 Blocking Antibody in Patients With Advanced Solid Tumors | NCT05180799 | Solid Tumor, Ad... NSCLC Urothelial Carc... Gastric Cancer Small Cell Lung... Hepatocellular ... Cervical Carcin... Melanoma Renal Cell Carc... Carcinoma | BA3071 Nivolumab Pembrolizumab | 18 Years - | BioAtla, Inc. | |
| Safety Study Using Weekly Infusions of BB-10901 in Patients With Small Cell Lung Cancer | NCT00065429 | Small Cell Lung... | BB-10901 | 18 Years - | ImmunoGen, Inc. | |
| A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors | NCT03517488 | Melanoma Breast Carcinom... Hepatocellular ... Urothelial Carc... Squamous Cell C... Renal Cell Carc... Colorectal Carc... Non-small Cell ... Gastric or Gast... Endometrial Car... Mesothelioma Neuroendocrine ... Cervical Cancer Small Cell Lung... Squamous Cell C... Castration-Resi... Nasopharyngeal ... Cholangiocarcin... Basal Cell Carc... Ovarian Carcino... Fallopian Tube ... Thymoma Thymic Carcinom... Squamous Cell C... Vulvar Carcinom... Solid Tumors Wi... Malignant Adnex... Non-squamous Ce... | XmAb20717 | 18 Years - | Xencor, Inc. | |
| PEI REGIMEN: A Therapeutic Option in Small Cell Lung Cancer? A Monoinstitutional Experience of 46 Consecutive Cases | NCT02324296 | Small Cell Lung... | ifosfamide | 18 Years - 75 Years | Arcispedale Santa Maria Nuova-IRCCS | |
| PEI REGIMEN: A Therapeutic Option in Small Cell Lung Cancer? A Monoinstitutional Experience of 46 Consecutive Cases | NCT02324296 | Small Cell Lung... | ifosfamide | 18 Years - 75 Years | Arcispedale Santa Maria Nuova-IRCCS | |
| Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLC | NCT04140526 | Non Small Cell ... Advanced Solid ... Metastatic Mela... Metastatic Head... Metastatic Rena... Metastatic Colo... Sarcomas Metastatic Pros... Ovarian Cancer Small Cell Lung... Metastatic Brea... Pancreas Cancer Gastric Cancer Esophageal Canc... Gastroesophagea... Cervical Cancer Adenoid Cystic ... Salivary Gland ... Urothelial Carc... | ONC-392 Pembrolizumab Docetaxel | 18 Years - | OncoC4, Inc. | |
| Study of Amrubicin in Patients With Small Cell Lung Cancer Refractory or Progressive to Prior Therapy | NCT00375193 | Small Cell Lung... | Amrubicin | 18 Years - | Celgene | |
| Alisertib (MLN8237) in Combination With Weekly Paclitaxel in East Asian Patients With Advanced Solid Tumors | NCT02367352 | Advanced Solid ... Ovarian Cancer Small Cell Lung... | Alisertib Paclitaxel | 18 Years - | Takeda | |
| Molecular Signatures of Relapse in Tissue Samples From Patients With Small Cell Lung Cancer Who Are Receiving Cisplatin and Etoposide | NCT02250404 | Small Cell Lung... | cytology specim... laboratory biom... | 18 Years - | University of Southern California | |
| A Dose Escalation Study to Investigate the Safety, Pharmacokinetics (PK), Pharmacodynamics (PD), and Clinical Activity of GSK525762 Plus Trametinib in Subjects With Solid Tumors | NCT03266159 | Solid Tumours | GSK525762 Besyl... Trametinib tabl... | 18 Years - | GlaxoSmithKline | |
| A Multicenter Expanded Access Treatment Protocol of Lurbinectedin in Previously Treated SCLC in the USA | NCT04291937 | Small Cell Lung... | Lurbinectedin | 18 Years - | Jazz Pharmaceuticals | |
| Abscopal Effect for Metastatic Small Cell Lung Cancer | NCT02542137 | Small Cell Lung... Radiotherapy Thymalfasin | Radiotherapy Thymalfasin | 19 Years - | Zhejiang Provincial People's Hospital | |
| Study of Irinotecan Liposome Injection (ONIVYDE®) in Patients With Small Cell Lung Cancer | NCT03088813 | Small Cell Lung... | Irinotecan lipo... Topotecan | 18 Years - | Ipsen | |
| MOnaliZumab in Combination With durvAlumab (MEDI4736) Plus Platinum-based chemotheRapy for First-line Treatment of Extensive Stage Small Cell Lung Cancer | NCT05903092 | Small Cell Lung... SCLC Extensive Stage... | Durvalumab Monalizumab Carboplatin or ... Etoposide | 18 Years - | Hoosier Cancer Research Network | |
| Phase II, Single-arm Study of AZD1775 Monotherapy in Relapsed Small Cell Lung Cancer Patients | NCT02593019 | Small Cell Lung... | AZD1775 | 20 Years - | Samsung Medical Center | |
| Phenethyl Isothiocyanate in Preventing Lung Cancer in People Who Smoke | NCT00005883 | Lung Cancer | phenethyl isoth... | - | NYU Langone Health | |
| Surufatinib Combined With Irinotecan as a Second-line Treatment for Small Cell Lung Cancer | NCT05595889 | Small Cell Lung... Angiogenesis Chemotherapy Ef... | Surufatinib Irinotecan | 18 Years - 80 Years | Fujian Cancer Hospital | |
| A Study of Subjects With Previously Untreated Extensive-Stage Small-Cell Lung Cancer (SCLC) Treated With Platinum Plus Etoposide Chemotherapy With or Without Darbepoetin Alfa | NCT00119613 | Small Cell Lung... | placebo darbepoetin alf... | 18 Years - | Amgen | |
| Zileuton in Preventing Lung Cancer in Patients With Bronchial Dysplasia | NCT00056004 | Head and Neck C... Lung Cancer | zileuton | 18 Years - | Barbara Ann Karmanos Cancer Institute | |
| Screening Methods in Finding Lung Cancer Early in Current or Former Smokers | NCT00751660 | Lung Cancer Tobacco Use Dis... | laboratory biom... screening quest... bronchoscopic a... computed tomogr... endoscopic biop... quality-of-life... | 50 Years - 75 Years | British Columbia Cancer Agency | |
| Broccoli Sprout Extract in Preventing Lung Cancer in Smokers | NCT00255775 | Lung Cancer | broccoli sprout... complementary o... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Rovalpituzumab Tesirine (SC16LD6.5) in Recurrent Small Cell Lung Cancer | NCT01901653 | Recurrent Small... | Rovalpituzumab ... | 18 Years - | Stemcentrx | |
| Nivolumab and 177Lu-DOTA0-Tyr3-Octreotate for Patients With Extensive-Stage Small Cell Lung Cancer | NCT03325816 | Small Cell Lung... Small Cell Lung... | Nivolumab 177Lu-DOTA0-Tyr... | 18 Years - | Georgetown University | |
| Study of Sintlimab Maintenance Therapy in Patients With Extensive Small Cell Lung Cancer | NCT03983759 | Small Cell Lung... Extensive Disea... Adoptive Cellul... Chemotherapy Maintenance | sintilimab main... | 18 Years - 70 Years | Henan Cancer Hospital | |
| Bronchoscopic Intratumoral Chemotherapy for Small Cell Lung Cancer (SCLC) | NCT01487499 | Small Cell Lung... | Cisplatin | - | University of Florida | |
| Hyperthermia/Thermal Therapy With Chemotherapy to Treat Inoperable or Metastatic Tumors | NCT00178698 | Neuroendocrine ... Small Cell Lung... Non-Small Cell ... Gastric Cancer | thermochemother... Cisplatin, Gemc... thermochemother... | 18 Years - | The University of Texas Health Science Center, Houston | |
| Durvalumab(MEDI4736) and AZD6738 Combination Therapy in Relapsed Small Cell Lung Cancer Subjects | NCT04361825 | Small Cell Lung... | Durvalumab | 18 Years - | Samsung Medical Center | |
| Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking | NCT00790569 | Bladder Cancer Cervical Cancer Esophageal Canc... Gastric Cancer Head and Neck C... Kidney Cancer Leukemia Liver Cancer Lung Cancer Pancreatic Canc... Tobacco Use Dis... | nicotine varenicline placebo | 18 Years - 120 Years | Butler Hospital | |
| PCI for Patients With ES-SCLC After RCT:a Prospective Randomized Study | NCT04535739 | Small-cell Lung... | prophylactic cr... | 18 Years - 65 Years | ChineseAMS | |
| Phase Ib/II Study of Chiauranib in Patients With Small Cell Lung Cancer | NCT03216343 | Small Cell Lung... | Chiauranib | 18 Years - 75 Years | Chipscreen Biosciences, Ltd. | |
| Lisinopril in Reducing Shortness of Breath Caused by Radiation Therapy in Patients With Lung Cancer | NCT01880528 | Dyspnea Non-small Cell ... Small Cell Lung... | lisinopril placebo | 18 Years - | Mayo Clinic | |
| INS316 Compared With Saline for Sputum Collection in Diagnosing Lung Cancer | NCT00033527 | Lung Cancer | INS316 sputum cytology | 18 Years - | National Cancer Institute (NCI) | |
| Irinotecan Liposome Combined With Anlotinib as Second-line Regimen for SCLC | NCT06258642 | Small Cell Lung... | Irinotecan Lipo... Anlotinib | 18 Years - 75 Years | Fudan University | |
| A Study to Treat Small Cell Lung Cancer With a Combination of Cisplatin, Pemetrexed, and Radiotherapy | NCT00447421 | Small Cell Lung... Carcinoma, Smal... SCLC | pemetrexed cisplatin radiation | 18 Years - | Eli Lilly and Company | |
| Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer | NCT00613626 | Small Cell Lung... | Cisplatin Etoposide Placebo ZD6474 | 18 Years - | Hoosier Cancer Research Network | |
| Safety and Efficacy Clinical Study of SNS-595 in Patients With Advanced Small Cell Lung Cancer | NCT00298896 | Carcinoma, Smal... Small Cell Lung... | SNS-595 | 18 Years - | Sunesis Pharmaceuticals | |
| Safety and Efficacy of XmAb18087 ± Pembrolizumab in Advanced Merkel Cell Carcinoma or Extensive-stage Small Cell Lung Cancer | NCT04590781 | Merkel Cell Car... Small Cell Lung... | XmAb18087 XmAb18087 ± Pem... | 18 Years - | Xencor, Inc. | |
| Chemotherapy and Radiotherapy to Treat Patients With Limited Stage of Small Cell Lung Cancer (SCLC) | NCT00494026 | Small Cell Lung... | pemetrexed carboplatin radiotherapy | 18 Years - | Eli Lilly and Company | |
| Diflomotecan (BN80915) Administered Once Every 3 Weeks in Treating Patients With Sensitive Small Cell Lung Cancer (SCLC) | NCT00080015 | Small Cell Lung... | Diflomotecan (B... | 18 Years - | Ipsen | |
| Toripalimab in Combination With Platinum Plus Etoposidein Patients With Extensive-Stage Small Cell Lung Cancer | NCT04012606 | Small Cell Lung... | TORIPALIMAB INJ... | 18 Years - | Shanghai Junshi Bioscience Co., Ltd. | |
| Selinexor in Treating Patients With Relapsed Small Cell Lung Cancer | NCT02351505 | Recurrent Small... | Selinexor Laboratory Biom... Pharmacological... | 18 Years - | Ohio State University Comprehensive Cancer Center | |
| Pilot Project of Adaptive Thoracic Radiotherapy for Small Cell Lung Cancer | NCT01426841 | Small Cell Lung... | Adaptive Radiat... | 18 Years - | AHS Cancer Control Alberta | |
| Proteomics in Small Cell Lung Cancer | NCT05623956 | Small Cell Lung... | 18 Years - | Aalborg University Hospital | ||
| Metronomic Docetaxel and Bevacizumab in Patients With Small Cell Lung Cancer | NCT00755157 | Small Cell Lung... | Docetaxel Bevacizumab | 18 Years - | University Hospital of Crete | |
| Phase 2 Safety and Efficacy Evaluation of AL8326 in ≥2nd Line SCLC | NCT05363280 | Small Cell Lung... | AL8326 low dose... AL8326 middle d... AL8326 high dos... | 18 Years - | Advenchen Laboratories, LLC | |
| Safety Study Using Weekly Infusions of BB-10901 in Patients With Small Cell Lung Cancer | NCT00065429 | Small Cell Lung... | BB-10901 | 18 Years - | ImmunoGen, Inc. | |
| IMM2520, a PD-L1 and CD47 Bispecific Antibody in Patients With Advanced Solid Tumors | NCT05780307 | Advanced Solid ... Non-small Cell ... Small Cell Lung... Breast Cancer Squamous Cell C... Colorectal Canc... | IMM2520 | 18 Years - | ImmuneOnco Biopharmaceuticals (Shanghai) Inc. | |
| Study Comparing Amrubicin Versus Topotecan in Patients With Small Cell Lung Cancer Who Have Responded to Prior Therapy. | NCT00319969 | Small Cell Lung... | Amrubicin Topotecan | 18 Years - | Celgene | |
| Phenethyl Isothiocyanate in Preventing Lung Cancer in People Who Smoke | NCT00005883 | Lung Cancer | phenethyl isoth... | - | NYU Langone Health | |
| Bevacizumab in Extensive Small Cell Lung Cancer | NCT00930891 | Small Cell Lung... | Standard Chemot... Experimental Tr... Prerandomizatio... | 18 Years - 75 Years | Intergroupe Francophone de Cancerologie Thoracique | |
| Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies | NCT03881488 | Locally Advance... Metastatic Canc... Non-small Cell ... Small Cell Lung... Mesothelioma Melanoma Head and Neck C... | CTX-471 Pembrolizumab (... | 18 Years - | Compass Therapeutics | |
| Study of Durvalumab + Tremelimumab, Durvalumab, and Placebo in Limited Stage Small-Cell Lung Cancer in Patients Who Have Not Progressed Following Concurrent Chemoradiation Therapy | NCT03703297 | Small Cell Lung... | Durvalumab Tremelimumab Placebo | 18 Years - 130 Years | AstraZeneca | |
| Phase 3 Clinical Study of Chiauranib Capsule in Patients With Small-cell Lung Cancer | NCT04830813 | Small Cell Lung... | Chiauranib Placebo | 18 Years - 75 Years | Chipscreen Biosciences, Ltd. | |
| AZD 2811 Monotherapy in Relapsed Small Cell Lung Cancer Patients [SUKSES-N3] | NCT03366675 | Small Cell Lung... | AZD2811 | 20 Years - | Samsung Medical Center | |
| Exercise in Advanced Stage Lung Cancer Patients | NCT01881906 | Non Small Cell ... Small Cell Lung... | Usual care Exercise | 18 Years - | Rigshospitalet, Denmark | |
| Concurrent Chemo-Radiotherapy for Limited Disease Small Cell Lung Cancer (LD-SCLC) on Basis of FDG-PET-Scans | NCT00572923 | Small Cell Lung... | 18 Years - | Maastricht Radiation Oncology | ||
| Camrelizumab Combined With Apatinib, Etoposide and Cisplatin Treat Small-cell Lung Cancer. | NCT04490421 | Lung Neoplasm Small Cell Lung... PD-1 Inhibitors | Camrelizumab co... | 18 Years - 75 Years | Fuzhou General Hospital | |
| Trial of Belotecan/Cisplatin in Chemotherapy Naive Small Cell Lung Cancer Patient | NCT00826644 | Carcinoma, Smal... | Belotecan Etoposide Cisplatin | 19 Years - 80 Years | Chonnam National University Hospital | |
| Efficacy and Biomarker Explanation of IBI-322 Plus Lenvatinib on Extensive Stage Small Cell Lung Cancer | NCT05296603 | Small Cell Lung... | IBI-322 Plus Le... | 18 Years - | Hunan Province Tumor Hospital | |
| Trial of EP0057, a Nanoparticle Camptothecin With Olaparib in People With Relapsed/Refractory Small Cell Lung Cancer | NCT02769962 | Urothelial Carc... Urothelial Canc... Lung Neoplasms Small Cell Lung... Prostate Cancer | EP0057 olaparib | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| A Study of a New Chemotherapy Agent in Combination With Cisplatin to Treat Small Cell Lung Cancer | NCT00359359 | Carcinoma, Smal... | Sagopilone (BAY... Cisplatin | 18 Years - | Bayer | |
| Combined Simvastatin and Irinotecan in Treating ES-SCLC Patients Relapsed From 1st Chemotherapy | NCT04985201 | Small Cell Lung... | Irinotecan Simvastatin | 18 Years - 75 Years | Shanghai Pulmonary Hospital, Shanghai, China | |
| Chiauranib for Advanced Solid Malignant Tumors and Relapsed/Refractory SCLC. | NCT05271292 | Small Cell Lung... Advanced Solid ... | Chiauranib | 18 Years - | Chipscreen Biosciences, Ltd. | |
| Efficacy and Safety of DEB-BACE Combined With Serplulimab in First-line Treatment of SCLC | NCT06364046 | Carcinoma Small Cell Lung... | Drug-eluting be... Serplulimab Intravenous che... | 18 Years - | The Central Hospital of Lishui City | |
| Phase I Study of Gene Induction Mediated by Sequential Decitabine/Depsipeptide Infusion With or Without Concurrent Celecoxib in Subjects With Pulmonary and Pleural Malignancies | NCT00037817 | Advanced Esopha... Primary Small C... Non-Small-Cell ... Pleural Mesothe... Cancers of Non-... | Decitabine Depsipeptide Celecoxib | 18 Years - 65 Years | National Institutes of Health Clinical Center (CC) | |
| Interactive Voice Response (IVR) Symptom Assessment in Non-Small Cell Lung Cancer (NSCLC) Patients | NCT00423436 | Lung Cancer | Questionnaire Interactive Voi... IVR Plus Triage | 18 Years - | M.D. Anderson Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
